DMIIR
Drugs Made In America Acquisition II Corp.
NASDAQ · Financial Services · Asset Management · US
$0.07
−11.07%Price chart
Aug 14Aug 20Aug 25Aug 31Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.09
From 52W high−58.31%
Volume0.00
Market cap$4.37M
P/E (TTM)0.3x
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$0.09
From 52W high
−58.31%
Volume
0.00
Market cap
$4.37M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.5x
P/E (TTM)
0.3x
RSI (14)
54.3
MomentumView details →
1D Return
−11.07%
YTD Return
−33.43%
Similar companies
Latest newsMore news →
No recent news for DMIIR.